India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines – The Hindu

India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines  The Hindu India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines  The Hindu  Top stories – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *